display
Vaccine maker AstraZeneca has assured that its corona vaccine is safe.
"An analysis of our safety data of more than 10 million records has shown no evidence of an increased risk of pulmonary embolism or deep vein thrombosis," said a company spokesman on Friday.
This applies to all ages, genders, countries or batches of the AstraZeneca vaccine.
"In fact, these events occur less often among vaccinated people than in the general population," it said.
Astrazeneca also received support from the European Medicines Agency (EMA).
This came to the conclusion that the proportion of thrombosis sufferers after vaccination with the preparation corresponds to the spontaneous occurrence of this disease in the normal population.
As of March 10, the EMA had recorded 30 cases of “thromboembolic events” in nearly five million people vaccinated with the Astrazeneca drug.
On Thursday the Danish health authority reported "severe cases" of blood clots in people vaccinated with the vaccine.
However, it has not yet been conclusively clarified whether there is a connection between the vaccinations and the coagulation disorders.
According to the Danish health authorities, one person died after being vaccinated.
As a result, other countries such as Norway, Iceland, Thailand and Bulgaria had also suspended vaccinations with the AstraZeneca agent.
Because of one death and three sick people, Austria, Estonia and Lithuania had suspended the use of a certain batch of the vaccine as a precaution.
display
Some EU countries such as Sweden, Poland and Germany, however, said they would stick to the vaccine.
Germany is also not suspending vaccinations with the preparation.
display
Buy antigen self-tests online now
Take a nasal swab, read the result on the test strip within 15 minutes and find out whether you have Covid-19.
Order 10 pieces from APONEO Order 25 pieces from APONEO